Sign In
Buy PCRX
$22.32
+0.0700 (+0.315%)
At Close: Jun 03, 2026
Pacira Biosciences (NASDAQ:PCRX) Reaches New 12-Month High on Analyst Upgrade
01:18am, Tuesday, 14'th Jul 2020
Pacira Biosciences Inc (NASDAQ:PCRX)’s share price hit a new 52-week high during mid-day trading on Monday after Jefferies Financial Group raised their price target on the stock from $53.00 to $69.0
Pacira Biosciences (NASDAQ:PCRX) Earns “Buy” Rating from HC Wainwright
08:58am, Monday, 13'th Jul 2020
Pacira Biosciences (NASDAQ:PCRX)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Monday, The Fly reports. They presently have a $
Two Sigma Advisers LP Sells 47,800 Shares of Pacira Biosciences Inc (NASDAQ:PCRX)
07:40am, Sunday, 12'th Jul 2020
Two Sigma Advisers LP cut its holdings in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 85.2% during the first quarter, Holdings Channel.com reports. The firm owned 8,276 shares of the company’s
Did Hedge Funds Make The Right Call On Pacira Biosciences Inc (PCRX)?
11:02pm, Saturday, 11'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
12:00am, Friday, 10'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 9)
Affimed NV (NASDAQ: AFMD)...
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
12:00am, Wednesday, 08'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)
AbbVie Inc (NYSE: ABBV)...
Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025
11:51pm, Tuesday, 07'th Jul 2020
Pacira BioSciences, Inc. (PCRX) today announced the pricing of $350.0 million aggregate principal amount of convertible senior notes due 2025 (the “notes”) in a private placement to qualified inst
Pacira BioSciences, Inc. Announces Proposed Offering of $300.0 Million Aggregate Principal Amount of Convertible Senior Notes
08:02pm, Monday, 06'th Jul 2020
Pacira BioSciences, Inc. (PCRX) today announced that it intends to offer, subject to market and other conditions, $300.0 million aggregate principal amount of convertible senior notes due 2025 (the �
Pacira BioSciences Reports Preliminary Total Revenue of $75.5 Million for Second Quarter of 2020
08:01pm, Monday, 06'th Jul 2020
Pacira BioSciences, Inc. (PCRX), a leading provider of innovative non-opioid pain management options, today reported preliminary unaudited net revenue of $75.5 million for the second quarter of 2020,
Pacira Biosciences (NASDAQ:PCRX) Given New $64.00 Price Target at Needham & Company LLC
07:44am, Monday, 06'th Jul 2020
Pacira Biosciences (NASDAQ:PCRX) had its price objective boosted by analysts at Needham & Company LLC from $52.00 to $64.00 in a research report issued on Monday, Briefing.com Automated Import reports
Pacira Biosciences (NASDAQ:PCRX) Earns Overweight Rating from Piper Sandler
07:44am, Monday, 06'th Jul 2020
Pacira Biosciences (NASDAQ:PCRX)‘s stock had its “overweight” rating reiterated by equities research analysts at Piper Sandler in a research report issued to clients and investors on Monday, The
So far Sunday, July 5, NASDAQ is down -2.97% and the S&P is down -2.01%. Here are this morning’s most
So far Saturday, July 4, NASDAQ is down -2.97% and the S&P is down -2.01%. Here are this morning’s most
Northland Securities Raises Pacira Biosciences (NASDAQ:PCRX) Price Target to $54.00
08:20am, Saturday, 04'th Jul 2020
Pacira Biosciences (NASDAQ:PCRX) had its target price hoisted by Northland Securities from $50.00 to $54.00 in a report released on Tuesday, The Fly reports. The firm currently has a market perform ra
